Related references
Note: Only part of the references are listed.(-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression
Xiang Chang et al.
EXPERIMENTAL CELL RESEARCH (2015)
Epigenetic linkage of aging, cancer and nutrition
Michael Daniel et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2015)
(-)-Epigallocatechin-3-gallate induces cancer cell apoptosis via acetylation of amyloid precursor protein
Qian Hu et al.
MEDICAL ONCOLOGY (2015)
Epigenetic regulation in amyloid precursor protein and the Lesch-Nyhan syndrome
Khue Vu Nguyen
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Epigenetic changes in the progression of Alzheimer's disease
M. A. Bradley-Whitman et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2013)
Epigenetics in Alternative Pre-mRNA Splicing
Reini F. Luco et al.
CELL (2011)
Epigenetic mechanisms in Alzheimer's disease
Diego Mastroeni et al.
NEUROBIOLOGY OF AGING (2011)
Regulation of apoptosis-associated genes by histone deacetylase inhibitors: implications in cancer therapy
Ali R. Jazirehi
ANTI-CANCER DRUGS (2010)
Histone Deacetylase Inhibitor Valproic Acid Inhibits Cancer Cell Proliferation via Down-regulation of the Alzheimer Amyloid Precursor Protein
Vivek Venkataramani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Induction of Terminal Differentiation in Melanoma Cells on Downregulation of β-Amyloid Precursor Protein
Michelle G. Botelho et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Cancer linked to Alzheimer disease but not vascular dementia
C. M. Roe et al.
NEUROLOGY (2010)
Strategies in Developing Promising Histone Deacetylase Inhibitors
Lei Zhang et al.
MEDICINAL RESEARCH REVIEWS (2010)
Recent advances in histone deacetylase targeted cancer therapy
Isamu Hoshino et al.
SURGERY TODAY (2010)
Targeting the correct HDAC(s) to treat cognitive disorders
Andre Fischer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Amyloid Precursor Protein Is a Primary Androgen Target Gene That Promotes Prostate Cancer Growth
Ken-ichi Takayama et al.
CANCER RESEARCH (2009)
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
Rocio G. Urdinguio et al.
LANCET NEUROLOGY (2009)
Sodium valproate: an old drug with new roles
Natalia N. Nalivaeva et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Epigenetics in bladder cancer
Hideki Enokida et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Decreased acetylation of histone H3 in renal cell carcinoma: A potential target of histone deacetylase inhibitors
Kent Kanao et al.
JOURNAL OF UROLOGY (2008)
Targeting histone deacetylase in cancer therapy
Hsiang-Yu Lin et al.
MEDICINAL RESEARCH REVIEWS (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma
TE Fandy et al.
NEOPLASIA (2005)
Increased expression of amyloid precursor protein in oral squamous cell carcinoma
SY Ko et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Cooperation between complexes that regulate chromatin structure and transcription
GJ Narlikar et al.
CELL (2002)
Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene
JR Murrell et al.
ARCHIVES OF NEUROLOGY (2000)
Share Paper
